Table 1 Correlation between CNDP2 expression and clinicopathological characteristics.
| Â | Underexpression of CNDP2 [n (%)] | Normal expression of CNDP2 [n (%)] | P |
|---|---|---|---|
Sex | Â | Â | 0.855 |
Male | 89 (67.4) | 33 (66) | Â |
Female | 43 (32.6) | 17 (34) | Â |
Age (years) | Â | Â | 0.07 |
>60 | 62 (47) | 31 (62) | Â |
≤60 | 70 (53) | 19 (38) |  |
Tumor size (cm) | Â | Â | 0.638 |
<6 | 79 (59.8) | 28 (56) | Â |
| Â | 53 (40.2) | 22 (44) | Â |
Site | Â | Â | 0.016 |
Cardia and fundus | 35 (26.5) | 5 (10) | Â |
Corpus | 34 (25.8) | 20 (40) | Â |
Antrum | 63 (47.7) | 25 (50) | Â |
Type | Â | Â | 0.013 |
Tubular adenocarcinoma | 38 (28.8) | 26 (52) | Â |
Mucosal adenocarcinoma | 43 (32.6) | 10 (20) | Â |
Signet-ring cell carcinoma | 51 (38.6) | 14 (28) | Â |
Disease stage | Â | Â | 0.044 |
I and II | 47 (35.6) | 26 (52) | Â |
III and IV | 85 (64.4) | 24 (48) | Â |
pT stage | Â | Â | 0.01 |
T0-T2 | 37 (28) | 5 (10) | Â |
T3 and T4 | 95 (72) | 45 (90) | Â |
pN stage | Â | Â | 0.193 |
N0 | 42 (31.8) | 11 (22) | Â |
N1-3 | 90 (68.2) | 39 (78) | Â |
Total | 132 | 50 | Â |